细胞名称:人骨髓白血病细胞Kasumi-3
产品规格:T25培养瓶x1;1.5ml冻存管x2
细胞数量:1x10^6;1x10^6
保存温度:37℃;-198℃
运输方式:常温保温运输;干冰运输
安全等级:1
用途限制:仅供科研3类
培养体系:DMEM(HYCLONE SH30022.01)+10%FBS+1%三抗
培养温度:37℃
二氧化碳浓度:5%
简介:人骨髓白血病细胞Kasumi-3取自57岁男性供体
注释
:Part of:MD Anderson Cell Lines Project.
Population:Japanese.
Doubling time:55-60 hours(PubMed=8613429);~3-4 days(DSMZ).
Omics:Protein expression by reverse-phase protein arrays.
Omics:SNP array analysis.
Omics:Transcriptome analysis.
Derived from sampling site:Bone marrow myeloblasts.
基因突变
HLA信息
/
STR信息
Amelogenin X
CSF1PO 12
D3S1358 14,15
D5S818 13
D7S820 11,12
D8S1179 14,16
D13S317 11,12
D16S539 12
D18S51 12,13
D21S11 29
FGA 22,23
Penta D 8,11
Penta E 15,20
TH01 6
TPOX 8,11
vWA 16,17
参考文献
PubMed=8613429;DOI=10.1111/j.1349-7006.1996.tb00216.x
Asou H.,Suzukawa K.,Kita K.,Nakase K.,Ueda H.,Morishita K.,Kamada N.
Establishment of an undifferentiated leukemia cell line(Kasumi-3)with t(3;7)(q27;q22)and activation of the EVI1 gene.
Jpn.J.Cancer Res.87:269-274(1996)
DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In)ISBN 9780122219702;pp.1-733;Academic Press;London(2001)
PubMed=14504097;DOI=10.1182ood-2003-02-0418
Taketani T.,Taki T.,Sugita K.,Furuichi Y.,Ishii E.,Hanada R.,Tsuchida M.,Sugita K.,Ida K.,Hayashi Y.
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.
Blood 103:1085-1088(2004)
PubMed=23955599;DOI=10.1038.2731
Kon A.,Shih L.-Y.,Minamino M.,Sanada M.,Shiraishi Y.,Nagata Y.,Yoshida K.,Okuno Y.,Bando M.,Nakato R.,Ishikawa S.,Sato-Otsubo A.,Nagae G.,Nishimoto A.,Haferlach C.,Nowak D.,Sato Y.,Alpermann T.,Nagasaki M.,Shimamura T.,Tanaka H.,Chiba K.,Yamamoto R.,Yamaguchi T.,Otsu M.,Obara N.,Sakata-Yanagimoto M.,Nakamaki T.,Ishiyama K.,Nolte F.,Hofmann W.K.,Miyawaki S.,Chiba S.,Mori H.,Nakauchi H.,Koeffler H.P.,Aburatani H.,Haferlach T.,Shirahige K.,Miyano S.,Ogawa S.
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Nat.Genet.45:1232-1237(2013)
PubMed=28196595;DOI=10.1016/j.ccell.2017.01.005
Li J.,Zhao W.,Akbani R.,Liu W.,Ju Z.,Ling S.,Vellano C.P.,Roebuck P.,Yu Q.,Eterovic A.K.,Byers L.A.,Davies M.A.,Deng W.,Gopal Y.N.V.,Chen G.,von Euw E.M.,Slamon D.J.,Conklin D.,Heymach J.V.,Gazdar A.F.,Minna J.D.,Myers J.N.,Lu Y.,Mills G.B.,Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)
PubMed=32180206;DOI=10.1007/s13577-020-00347-5
Kasai F.,Asou H.,Ozawa M.,Kobayashi K.,Kuramitsu H.,Satoh M.,Kohara A.,Kaneko Y.,Kawamura M.
Kasumi leukemia cell lines:characterization of tumor genomes with ethnic origin and scales of genomic alterations.
Hum.Cell 33:0-0(2020)
细胞操作说明下载:细
胞操作说明